Why the study?
Does oral disopyramide phosphate reduce the frequency of cardiac ectopic depolarizations compared to placebo in outpatients with arrhythmias?
Does oral disopyramide phosphate reduce the frequency of cardiac ectopic depolarizations compared to placebo in outpatients with arrhythmias?
Disopyramide phosphate is an effective and well-tolerated oral antiarrhythmic agent for reducing ectopic depolarizations and ventricular arrhythmias in outpatients.
No takes yet. Share an insight, caveat, or question.
Supports outpatient disopyramide for ectopy suppression; leaves open larger trials on outcomes and safety.
Vismara et al. (1974) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: